Latest Period
Q2 2026
Security Snapshot
Immunovant, Inc. - Common Stock, $0.0001 par value per share (IMVT) Institutional Ownership
CUSIP: 45258J102
13F Institutional Holders and Ownership History from Q4 2019 to Q2 2026
Institutions Reporting
225
Shares (Excl. Options)
110,386,852
Price
$38.53
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- IMVT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 110,386,852
- Total 13F value
- $4,251,132,206
- Portfolio coverage rank
- 0.01%
- Share change
- -187,867
- Value change
- +$29,590,212
- Number of holders
- 225
- Shares outstanding
- 205,300,022
- SEC-reported price per share
- $38.61
- Insider filing price
- $38.61
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- IMVT - Immunovant, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 45258J102.
- 225 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 214 to 225 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,746,897,525 to $4,251,132,206.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 225 institutions filings for Q2 2026.
Security key
45258J102
Latest holder period
Q2 2026
13F holders
225
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
IMVT full holder history
Immunovant, Inc. SEC filings
Immunovant, Inc. company facts
Immunovant, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45258J102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
IMVT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | 56% | -1.8% | $2,812,776,314 | +$413,666,650 | 113,327,007 | +17% | Roivant Sciences Ltd. | 12 Dec 2025 |
| FMR LLC | 8.4% | -17% | $237,440,423 | -$37,858,433 | 14,729,555 | -14% | FMR LLC | 30 Sep 2025 |
| Deep Track Capital, LP | 4.6% | -17% | $361,502,544 | -$6,147,456 | 9,341,151 | -1.7% | Deep Track Capital, LP | 30 Jun 2026 |
As of 30 Jun 2026, 225 institutional investors reported holding 110,386,852 shares of Immunovant, Inc. - Common Stock, $0.0001 par value per share (IMVT). This represents 54% of the company’s total 205,300,022 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
46%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 7.9% | 16,186,469 | -4.5% | 0.03% | $623,664,634 |
| Deep Track Capital, LP | 4.5% | 9,341,151 | -19% | 5.3% | $359,914,548 |
| BlackRock, Inc. | 3.5% | 7,180,897 | +9.2% | 0% | $276,679,973 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2.8% | 5,805,000 | +275% | 1.3% | $223,666,650 |
| BAKER BROS. ADVISORS LP | 2.6% | 5,435,220 | -0.42% | 1% | $209,419,027 |
| STATE STREET CORP | 2.2% | 4,617,005 | +1.7% | 0.01% | $177,893,203 |
| MORGAN STANLEY | 2.2% | 4,534,833 | +17% | 0.01% | $174,727,164 |
| TCG Crossover Management, LLC | 2.2% | 4,457,988 | 0% | 4.1% | $171,766,278 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9% | 3,910,509 | +5.5% | 0.01% | $150,671,912 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8% | 3,638,681 | +0.51% | 0% | $140,198,379 |
| JENNISON ASSOCIATES LLC | 1.6% | 3,310,238 | +3.6% | 0.08% | $127,543,468 |
| RTW INVESTMENTS, LP | 1.5% | 3,177,849 | 0% | 1% | $122,442,522 |
| Two Seas Capital LP | 1.5% | 3,148,505 | -1.7% | 4.6% | $121,311,898 |
| ADAR1 Capital Management, LLC | 1.1% | 2,330,716 | -13% | 4.3% | $89,802,487 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 2,234,602 | +6.8% | 0% | $86,115,373 |
| T. Rowe Price Investment Management, Inc. | 1.1% | 2,222,101 | -38% | 0.06% | $85,618,000 |
| Woodline Partners LP | 0.96% | 1,975,869 | 0% | 0.24% | $76,130,233 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.89% | 1,829,210 | +439% | 0.01% | $70,481,000 |
| GOLDMAN SACHS GROUP INC | 0.85% | 1,751,183 | -1.9% | 0.01% | $67,473,081 |
| ARMISTICE CAPITAL, LLC | 0.85% | 1,736,000 | -51% | 1.9% | $66,888,080 |
| Alpine Global Management, LLC | 0.67% | 1,375,000 | -48% | 8.7% | $52,978,748 |
| PERCEPTIVE ADVISORS LLC | 0.66% | 1,357,383 | -15% | 0.81% | $52,299,967 |
| D. E. Shaw & Co., Inc. | 0.6% | 1,240,654 | 0.03% | $47,802,399 | |
| BANK OF AMERICA CORP /DE/ | 0.58% | 1,181,452 | +32% | 0% | $45,521,345 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.5% | 1,022,513 | +66% | 0.03% | $39,397,426 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
27
Latest
Q2 2026
Rows shown
1-25 of 27
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 110,386,852 | $4,251,132,206 | +$29,590,212 | $38.53 | 225 |
| 2026 Q1 | 110,594,133 | $2,746,897,525 | +$42,456,538 | $24.84 | 214 |
| 2025 Q4 | 108,607,805 | $2,761,165,010 | +$365,946,432 | $25.42 | 195 |
| 2025 Q3 | 95,145,471 | $1,533,747,121 | -$22,890,328 | $16.12 | 183 |
| 2025 Q2 | 96,203,927 | $1,539,273,430 | +$25,954,256 | $16.00 | 167 |
| 2025 Q1 | 94,088,777 | $1,608,317,726 | +$221,642,111 | $17.09 | 191 |
| 2024 Q4 | 80,137,358 | $1,984,988,003 | -$10,994,227 | $24.77 | 186 |
| 2024 Q3 | 79,205,377 | $2,259,063,728 | +$130,270,111 | $28.51 | 182 |
| 2024 Q2 | 74,718,656 | $1,972,484,501 | +$94,283,095 | $26.40 | 195 |
| 2024 Q1 | 70,316,923 | $2,271,922,665 | +$28,234,974 | $32.31 | 208 |
| 2023 Q4 | 68,405,672 | $2,881,981,571 | +$25,897,847 | $42.13 | 227 |
| 2023 Q3 | 68,143,903 | $2,616,088,544 | +$461,829,770 | $38.39 | 179 |
| 2023 Q2 | 55,460,743 | $1,051,890,599 | -$33,129,073 | $18.97 | 145 |
| 2023 Q1 | 58,264,079 | $903,668,302 | +$20,897,901 | $15.51 | 140 |
| 2022 Q4 | 56,538,511 | $1,003,523,628 | +$261,143,310 | $17.75 | 132 |
| 2022 Q3 | 42,668,627 | $238,077,080 | +$13,851,662 | $5.58 | 107 |
| 2022 Q2 | 40,117,493 | $156,470,492 | +$2,266,222 | $3.90 | 87 |
| 2022 Q1 | 39,493,605 | $217,710,240 | -$1,326,202 | $5.51 | 108 |
| 2021 Q4 | 37,845,291 | $322,423,547 | -$6,093,696 | $8.52 | 118 |
| 2021 Q3 | 33,769,857 | $293,475,463 | -$50,043,046 | $8.69 | 115 |
| 2021 Q2 | 38,555,821 | $407,535,405 | -$67,673,203 | $10.57 | 110 |
| 2021 Q1 | 40,251,421 | $645,603,475 | -$273,082,395 | $16.04 | 118 |
| 2020 Q4 | 40,331,237 | $1,862,979,798 | +$41,257,802 | $46.19 | 146 |
| 2020 Q3 | 39,828,501 | $1,401,617,459 | +$384,378,297 | $35.19 | 116 |
| 2020 Q2 | 28,564,750 | $695,567,285 | +$388,041,409 | $24.35 | 87 |